Valion Bio Inc Quick Ratio (VBIO) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Valion Bio Inc   (VBIO)

Valion Bio Inc 's Quick Ratio

VBIO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.69 a new company low.

Within Medical Equipment & Supplies industry 129 other companies have achieved higher Quick Ratio than Valion Bio Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 872 to 2143.

Explain Quick Ratio?
How much Cash & cash equivalents VBIO´s has?
What are VBIO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VBIO Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 271.01 % 252.9 % 137.5 % 13.93 % 38.92 %
Y / Y Cash & cash equivalent Change 78.04 % 978.48 % 531.62 % 57.61 % -67.94 %
Quick Ratio MRQ 0.69 2.76 19.57 5.41 1.44
VBIO's Total Ranking # 2143 # 872 # 0 # 0 #
Seq. Current Liabilities Change 16.48 % 304.8 % 1.25 % -22.29 % 10.8 %
Seq. Cash & cash equivalent Change -70.78 % -42.94 % 266.52 % 191.39 % 76.98 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 130
Healthcare Sector # 693
Overall Market # 2143


Quick Ratio Statistics
High Average Low
26.44 5.59 0.69
(Mar 31 2021)   (Jun 30 2026)




Financial Statements
Valion Bio Inc 's Current Liabilities $ 3 Millions Visit VBIO's Balance sheet
Valion Bio Inc 's Cash & cash equivalent $ 2 Millions Visit VBIO's Balance sheet
Source of VBIO's Sales Visit VBIO's Sales by Geography


Cumulative Valion Bio Inc 's Quick Ratio

VBIO's Quick Ratio for the trailling 12 Months

VBIO Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 190.1 % 118.11 % 17.85 % -30.25 % -39.91 %
Y / Y Cash & cash equivalent TTM Growth 320.55 % 186.38 % 87.9 % -33.26 % -56.6 %
Quick Ratio TTM 3.66 5.19 6.31 2.96 2.52
Total Ranking TTM # 3752 # 3534 # 0 # 0 #
Seq. Current Liabilities TTM Growth 47.14 % 65.85 % 15.13 % 3.26 % 10.63 %
Seq. Cash & cash equivalent TTM Growth 3.77 % 36.47 % 145.69 % 20.86 % -29.33 %

Quick ratio ranking by company, industry and sector >> Back to VBIO Financial Strength Comparisons >> Go to Compare VBIO Quick Ratio to its Competitors

On the trailing twelve months basis Due to increase in Current Liabilities in the Q2 2026 to $3.05 millions, cumulative Quick Ratio decreased to 3.66 above the VBIO average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 193 other companies have achieved higher Quick Ratio than Valion Bio Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 3534 to 3752.

Explain Quick Ratio?
How much Cash & cash equivalents VBIO´s has?
What are VBIO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 194
Healthcare Sector # 869
Within the Market # 3752


trailing twelve months Quick Ratio Statistics
High Average Low
8.64 3.39 0.89
(Mar 31 2022)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Tactile Systems Technology Inc   1.83 $ 69.853  Millions$ 38.253  Millions
Tandem Diabetes Care Inc   1.80 $ 455.996  Millions$ 253.005  Millions
Inspire Medical Systems inc   1.79 $ 127.761  Millions$ 71.282  Millions
Warby Parker Inc   1.79 $ 292.674  Millions$ 163.480  Millions
Capsovision Inc   1.76 $ 9.077  Millions$ 5.158  Millions
Anika Therapeutics Inc   1.73 $ 38.412  Millions$ 22.147  Millions
Genedx Holdings Corp   1.71 $ 132.548  Millions$ 77.648  Millions
Beta Bionics Inc   1.70 $ 44.318  Millions$ 26.017  Millions
Merit Medical Systems Inc  1.70 $ 450.906  Millions$ 264.933  Millions
Seastar Medical Holding Corp  1.60 $ 6.959  Millions$ 4.353  Millions
Tela Bio Inc   1.59 $ 30.424  Millions$ 19.080  Millions
Conexeu Sciences Inc   1.55 $ 1.971  Millions$ 1.272  Millions
Inogen Inc   1.49 $ 105.539  Millions$ 70.864  Millions
Dariohealth Corp   1.49 $ 14.254  Millions$ 9.578  Millions
Myomo Inc   1.45 $ 15.686  Millions$ 10.805  Millions
Envoy Medical Inc   1.43 $ 19.679  Millions$ 13.807  Millions
Nephros Inc   1.40 $ 4.697  Millions$ 3.344  Millions
Envista Holdings Corporation  1.39 $ 1,125.600  Millions$ 807.300  Millions
Medtronic Plc  1.36 $ 16,068.000  Millions$ 11,799.000  Millions
Sanara Medtech Inc   1.31 $ 16.421  Millions$ 12.494  Millions
Globus Medical Inc   1.24 $ 595.142  Millions$ 479.347  Millions
Lucid Diagnostics Inc   1.21 $ 33.404  Millions$ 27.516  Millions
Sintx Technologies Inc   1.21 $ 3.590  Millions$ 2.977  Millions
Vaso Corporation  1.17 $ 38.291  Millions$ 32.863  Millions
Koru Medical Systems Inc   1.15 $ 8.288  Millions$ 7.180  Millions
Establishment Labs Holdings Inc   1.10 $ 71.157  Millions$ 64.558  Millions
Treace Medical Concepts Inc   1.10 $ 45.619  Millions$ 41.496  Millions
Resmed Inc   1.05 $ 1,469.234  Millions$ 1,395.110  Millions
Adagio Medical Holdings inc   1.02 $ 7.740  Millions$ 7.562  Millions
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions

Date modified: 2026-09-26T07:41:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.